3 completed, 1 recruiting, 1 withdrawn. 3 Phase 1, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Withdrawn 1 |
| Not applicable | 1 | Completed 1 |
Follow Justin Fraser: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Magnesium And Verapamil After Recanalization in Ischemia of the Cerebrum: a Clinical and Translational Study. Verapamil and Magnesium Sulfate, Placebo - Ischemic Stroke | Phase 1 | Completed | Justin Fraser | 10 | 2017-10-11 | 2020-06-24 |
| Brain, Blood And Clot or Tissue Registry And Collaboration Registry - Acute Ischemic Stroke, Cerebrovascular Disorders | Recruiting | Justin Fraser | 1000 | 2017-05-11 | 2026-03-04 | |
| Superselective Citicoline and Verapamil for Ischemic Neuroprotection and Greater Effective Response Verapamil and Citicoline, Placebo - Ischemic Stroke | Phase 1 | Withdrawn | Justin Fraser | 2016-08-01 | 2016-09-23 | |
| Stroke and Traumatic Acute Brain Injury Line Indicator System for Emergent Recognition (STABILISER-I) Lateral Flow Device - Ischemic Stroke, Hemorrhagic Stroke | Not applicable | Completed | Justin Fraser | 48 | 2015-03-25 | 2017-02-23 |
| Superselective Administration of VErapamil During Recanalization in Acute Ischemic Stroke Verapamil - Ischemic Stroke | Phase 1 | Completed | Justin Fraser | 11 | 2013-02-01 | 2017-01-23 |
Ischemic Stroke (5) · Stroke (2) · Brain Injuries, Traumatic (1) · Cerebrovascular Disorders (1) · Hemorrhagic Stroke (1) · Ischemia (1)
Verapamil (3) · Sodium Chloride (2) · Cytidine Diphosphate Choline (1) · Magnesium Sulfate (1) · Registries (1)
United States (5)
Justin F. Fraser, MD (2) · Justin F Fraser, MD (1) · Justin Fraswer, MD (1)
PMID 30064997, PMID 32010048, PMID 32641418, PMID 33768217, PMID 34250820, PMID 34558059, PMID 34728392, PMID 35141572, PMID 36179808, PMID 37280551, PMID 39154085